Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
China Biologic Agrees to Acquire TianXinFu from PWM 2017-10-12 20:30
China Biologic Receives Approval for Commercial Manufacturing of Human Fibrinogen 2017-10-09 20:30
Foresee Pharmaceuticals and TRPharm Announce License and Distribution Agreement 2017-09-27 19:56
VolitionRx Announces the Initial Sale of its New Nu.Q(TM) Research Kits 2017-09-22 20:30
$5.8 Million Awarded For Vaccine Engineering Will Use "Immune History" To Protect Against Bird Flu, A Collaboration Led By EpiVax 2017-09-18 23:29
Yisheng Biopharma Announces New Breakthrough Results on YS-ON-001 in Multiple Solid Tumor Experiments 2017-08-30 20:00
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice 2017-08-29 04:00
Lumosa Therapeutics Partners with Camargo Pharmaceutical Services in the Development of Naldebain(R) in the US 2017-08-28 14:09
CARsgen Launches First-in-Class Anti-Claudin18.2 CAR-T Clinical Trial 2017-08-10 14:10
Korea Institute of Science and Technology (KIST) Develops a New Drug for Alzheimer's Disease 2017-08-09 21:00
China Biologic Reports Financial Results for the Second Quarter of 2017 2017-08-03 05:00
First Human Subject Enrolled in Lumosa Therapeutics' Phase 1 Trial for LT3001, a New Drug Molecule for Acute Ischemic Stroke 2017-08-01 09:46
Frontier Biotech licenses 3BNC117, a novel broad-spectrum HIV neutralizing antibody 2017-07-25 19:50
China Biologic Products to Report Second Quarter of 2017 Financial Results 2017-07-19 20:00
Volition America, Inc. Announces a Colorectal Cancer Screening Trial containing approximately 13,500 Subjects in Collaboration with the Early Detection Research Network of the U.S. National Cancer Institute 2017-07-18 18:30
China's First Fully Human, Full-length Anti-PD-L1 Monoclonal Antibody Receives Approval to Initiate Clinical Trials by the China Food and Drug Administration 2017-07-17 20:50
Dr. Lilly Xu joins ChemPartner as Vice President and Head of DMPK and Exploratory Toxicology 2017-07-12 23:00
The U.S. Food & Drug Administration Approves Endari™ (L-glutamine oral powder), the First and Only Treatment for Sickle Cell Disease in Pediatric Patients and First in Nearly 20 Years for Adults 2017-07-10 08:15
Anaeropharma Science Announces Closing of Financing 2017-07-05 15:00
Institut Marques at the ESHRE Congress 2017-07-03 22:00
1 137 138 139 140 141 159